Clinical Trial Update: Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 Study [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating dose response, safety, and efficacy of nebulized SUN101 (EP-101) in chronic obstructive pulmonary disease has completed enrollment an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• SUN101 (EP-101)

Snippet

Sponsor: Sunovion Respiratory Development Inc. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-05-07